ct041,obinutuzumab
carsgen therapeutics,roche
['obinu', 'ct041']
at #ash22: new data supporting phase 3 vemircopan trials in paroxysmal nocturnal hemoglobinuria in a phase 2 study (nct04170023) vem improved intravascular hemolysis and prevented extravascular hemolysis in pnh, w/o new safety signals. stay tuned for more from #noeticinsight! 